Ubiquitin signaling in pancreatic ductal adenocarcinoma

被引:2
作者
Lv, Shengnan [1 ]
Zhang, Jian [1 ]
Peng, Xinyu [1 ]
Liu, Huan [1 ]
Liu, Yan [2 ]
Wei, Feng [1 ]
机构
[1] First Hosp Jilin Univ, Gen Surg Ctr, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China
[2] Chinese Acad Agr Sci, Changchun Vet Res Inst, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun, Peoples R China
基金
中国国家自然科学基金;
关键词
pancreatic ductal adenocarcinoma; ubiquitination; ubiquitin-protein ligases; deubiquitinating enzymes; proteolysis-targeting chimeras; CANCER PROGRESSION; ACHIEVES SAFE; BETA-CATENIN; PROMOTES; GROWTH; PROTAC; CHEMORESISTANCE; EXPRESSION; PROTEINS; PROLIFERATION;
D O I
10.3389/fmolb.2023.1304639
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignant tumor of the digestive system, characterized by rapid progression and being prone to metastasis. Few effective treatment options are available for PDAC, and its 5-year survival rate is less than 9%. Many cell biological and signaling events are involved in the development of PDAC, among which protein post-translational modifications (PTMs), such as ubiquitination, play crucial roles. Catalyzed mostly by a three-enzyme cascade, ubiquitination induces changes in protein activity mainly by altering their stability in PDAC. Due to their role in substrate recognition, E3 ubiquitin ligases (E3s) dictate the outcome of the modification. Ubiquitination can be reversed by deubiquitylases (DUBs), which, in return, modified proteins to their native form. Dysregulation of E3s or DUBs that disrupt protein homeostasis is involved in PDAC. Moreover, the ubiquitination system has been exploited to develop therapeutic strategies, such as proteolysis-targeting chimeras (PROTACs). In this review, we summarize recent progress in our understanding of the role of ubiquitination in the development of PDAC and offer perspectives in the design of new therapies against this highly challenging disease.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
    Pervin, Jannat
    Asad, Mohammad
    Cao, Shaolong
    Jang, Gun Ho
    Feizi, Nikta
    Haibe-Kains, Benjamin
    Karasinska, Joanna M.
    O'Kane, Grainne M.
    Gallinger, Steven
    Schaeffer, David F.
    Renouf, Daniel J.
    Zogopoulos, George
    Bathe, Oliver F.
    FRONTIERS IN GENETICS, 2023, 14
  • [42] The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
    Ren, Le
    Yu, Yue
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 179 - 187
  • [43] Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma
    Penchev, Vesselin R.
    Chang, Yu-Tai
    Begum, Asma
    Ewachiw, Theodore
    Gocke, Christian
    Li, Joey
    McMillan, Ross H.
    Wang, Qiuju
    Anders, Robert
    Marchionni, Luigi
    Maitra, Anirban
    Uren, Aykut
    Rasheed, Zeshaan
    Matsui, William
    MOLECULAR CANCER RESEARCH, 2019, 17 (04) : 929 - 936
  • [44] Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
    Hu, Dingyuan
    Ansari, Daniel
    Zhou, Qimin
    Sasor, Agata
    Hilmersson, Katarzyna Said
    Andersson, Roland
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
  • [45] Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma
    Chen, Jiong
    Chen, Long-Jiang
    Xia, Yun-Lian
    Zhou, Hang-Cheng
    Yang, Ren-Bao
    Wu, Wen
    Lu, Yin
    Hu, Li-Wei
    Zhao, Yue
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (07) : 1117 - 1127
  • [46] Clinical significance of serum survivin in patients with pancreatic ductal adenocarcinoma
    Ren, Y-Q.
    Zhang, H-Y.
    Su, T.
    Wang, X-H.
    Zhang, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (20) : 3063 - 3068
  • [47] Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma
    Satoh, Kennichi
    Hamada, Shin
    Shimosegawa, Tooru
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (02) : 140 - 146
  • [48] Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma
    Hang, Cheng
    Gong, Chen
    Fang, Yanfei
    Chen, Long
    Zhu, Jianxin
    JOURNAL OF MOLECULAR HISTOLOGY, 2021, 52 (02) : 187 - 196
  • [49] Galectin-1 Secreted by Activated Stellate Cells in Pancreatic Ductal Adenocarcinoma Stroma Promotes Proliferation and Invasion of Pancreatic Cancer Cells An In Vitro Study on the Microenvironment of Pancreatic Ductal Adenocarcinoma
    Xue, Xiaofeng
    Lu, Zipeng
    Tang, Dong
    Yao, Jie
    An, Yong
    Wu, Junli
    Li, Qiang
    Gao, Wentao
    Xu, Zekuan
    Qian, Zhuyin
    Dai, Cuncai
    Wei, Jishu
    Miao, Yi
    Jiang, Kuirong
    PANCREAS, 2011, 40 (06) : 832 - 839
  • [50] Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Status of KRAS
    Vivekanandhan, Sneha
    Madamsetty, Vijay S.
    Angom, Ramcharan Singh
    Dutta, Shamit Kumar
    Wang, Enfeng
    Caulfield, Thomas
    Pletnev, Alexandre A.
    Upstill-Goddard, Rosanna
    Asmann, Yan W.
    Chang, David
    Spaller, Mark R.
    Mukhopadhyay, Debabrata
    CANCERS, 2021, 13 (16)